Lufax Holding Ltd. (LU) Stock: Faces NYSE Non-Compliance Over Late Annual Report Filing

TLDR

Lufax stock trades at $2.90 as of 11:01 AM EDT. NYSE issued a notice for late filing of 2024 Form 20-F. Deadline to regain compliance is October 30, 2025. Delay due to planned auditor change pending June 25 approval. Listing remains unaffected for now, but risks exist if delays persist.

Lufax Holding Ltd. (NYSE: LU), currently trading at $2.90, has received a notice from the New York Stock Exchange for failing to file its 2024 annual report (Form 20-F) on time. This filing is critical to maintain listing compliance. The company now has until October 30, 2025, to submit the overdue report to regain full compliance with NYSE rules.

Lufax Holding Ltd. (LU) 

If Lufax fails to meet the October deadline, the exchange may offer an extension until April 30, 2026. Should the company still be unable to file by that time, the NYSE will begin suspension and delisting procedures. Importantly, the notice has no immediate impact on the company’s American depositary shares.

Auditor Change at the Core

The delay stems from a proposed change in Lufax’s auditors. The company’s board has resolved to appoint Ernst & Young and Ernst & Young Hua Ming LLP as new auditors. However, this appointment is contingent on approval during an extraordinary general meeting set for June 25, 2025.

Once the new auditors are confirmed, they will need time to conduct a complete audit of the 2024 financial statements. Lufax expects to file the report promptly once this process is completed.

Listing Still Intact—For Now

While the NYSE notice signals a regulatory setback, it does not suggest immediate financial distress. Auditor transitions can often lead to delays, especially among foreign issuers like Lufax that operate under complex compliance standards. The company’s continued cooperation with 85 financial institutions highlights its operational foundation despite the current uncertainty.

Still, the absence of current audited financials presents a transparency challenge for investors. The situation requires close monitoring as delays beyond October 2025 could increase the risk of delisting proceedings, particularly if an extension is denied.

Mixed Long-Term Returns

Lufax’s stock performance tells a mixed story. The company boasts a year-to-date return of 21.04% and a 1-year return of 42.68%, both outperforming the Hang Seng Index. However, its 3-year and 5-year returns are steeply negative at -63.49% and -93.74%, respectively.

Investors must weigh these returns alongside the company’s regulatory compliance and upcoming earnings report, expected between May 8 and May 20, 2025. The outcome of the auditor vote and subsequent filing will likely determine the stock’s near-term trajectory.

Investor Outlook Hinges on Execution

The path forward for Lufax will depend on its ability to execute the auditor transition efficiently and complete the audit within the NYSE’s timeline. Investor confidence may improve if the company delivers timely financial disclosures and demonstrates a clear roadmap for maintaining compliance. Until then, the stock may remain volatile as the market weighs regulatory risk against potential recovery.

The post Lufax Holding Ltd. (LU) Stock: Faces NYSE Non-Compliance Over Late Annual Report Filing appeared first on CoinCentral.